| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |